Nasdaq.com (US)
Eli Lilly vs. Novo Nordisk: Which GLP-1 Stock Is a Better Buy for 2027?
Key PointsEli Lilly has achieved explosive revenue growth fueled by its expanding portfolio of next-generation metabolic and weight-loss drugs.
Nasdaq.com (US)
Key PointsEli Lilly has achieved explosive revenue growth fueled by its expanding portfolio of next-generation metabolic and weight-loss drugs.